The effect of infusing hypoxanthine or xanthine on hypoxic-ischemic brain injury in rabbits

Brain Research

Volumn 1147, Issue 1, 2007, Pages 256-264

  Mink, Richard ^a,b   Johnston, Jill ^c  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Cardinal Glennon Hospital   (United States)

Author keywords

Cerebral hypoxia ischemia; Hypoxanthine; Neurofilaments; Oxygen free radicals; Xanthine; Xanthine oxidase dehydrogenase

Indexed keywords

HYPOXANTHINE; NEUROFILAMENT PROTEIN; OXYGEN RADICAL; XANTHINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; CEREBROSPINAL FLUID; CONTROLLED STUDY; DRUG EFFICACY; EVOKED SOMATOSENSORY RESPONSE; HYPOTHESIS; INTRACRANIAL PRESSURE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXYGEN BREATHING; PRIORITY JOURNAL; RABBIT; REPERFUSION;

ANALYSIS OF VARIANCE; ANIMALS; CEREBRAL CORTEX; ENZYME ACTIVATORS; EVOKED POTENTIALS, SOMATOSENSORY; FREE RADICALS; HYPOXANTHINE; HYPOXIA-ISCHEMIA, BRAIN; INFUSIONS, INTRAVENOUS; MALE; NEUROFILAMENT PROTEINS; RABBITS; RANDOM ALLOCATION; RECOVERY OF FUNCTION; XANTHINE; XANTHINE OXIDASE;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 34147158750     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.02.004     Document Type: Article

References (47)

1. 2, reactive oxygen species and lipid peroxidation in cerebral ischemia. Free Radical Biol. Med. 40 (2006) 376-387
2. Akdemir H., Aşik Z., Paşaog ̌lu H., Karaküçük X., Öktem X., and Koç R. The effect of allopurinol on focal cerebral ischemia: an experimental study in rabbits. Neurosurg. Rev. 24 (2001) 131-135
3. Betz A.L., Randall J., and Martz D. Xanthine oxidase is not a major source of free radicals in focal cerebral ischemia. Am. J. Physiol. 260 (1991) H3-H8
4. Camargo-De-Morais M., De Freitas M., De Mattos A.G., Schröder N., Zilles A.C., Lisboa C.S.F., Arteni M., Barlem A., Schierholt R., Zwetsch G., Souza C.A.B., Pessoa-Pureur R., and Netto C.A. Effects of brain ischemia on intermediate filaments of rat hippocampus. Neurochem. Res. 21 (1996) 595-602
5. Clarke R.S.B., Lai Y., Hickey R.W., Safar P.J., and Kochanek P.M. Hypoxic-ischemic encephalopathy: pathobiology and therapy of the postresuscitation syndrome in children. In: Fuhrman B.P., and Zimmerman J. (Eds). Pediatric Critical Care (2006), Mosby, Philadelphia 909-910
6. Das D.K., Engelman R.M., Clement R., Otani J., Prasad M.R., and Rao P.S. Role of xanthine oxidase inhibitor as free radical scavenger: a novel mechanism of action of allopurinol and oxypurinol in myocardial salvage. Biochem. Biophys. Res. Commun. 148 (1987) 314-319
7. Granger D.N., Rutili G., and McCord J.M. Superoxide radicals in feline intestinal ischemia. Gastroenterology 81 (1981) 22-29
8. Harmsen E., de Jong J.W., and Serruys P.W. Hypoxanthine production by ischemic heart demonstrated by high pressure liquid chromatography of blood purine nucleosides and oxypurines. Clin. Chim. Acta 115 (1981) 73-84
9. Haskó G., Sitkovsky M.V., and Szabó C. Immunomodulatory and neuroprotective effects on inosine. Trends Pharmacol. Sci. 25 (2004) 152-157
10. Haun S.E., Segeleon J.E., Trapp V.L., Clotz M.A., and Horrocks L.A. Inosine mediates the protective effect of adenosine in rat astrocyte cultures subjected to combined glucose-oxygen deprivation. J. Neurochem. 67 (1996) 2051-2059
11. Hurn P.D., Koehler R.C., Norris S.C., Blizzard K.K., and Traystman R.J. Dependence of cerebral energy phosphate and evoked potential recovery on end-ischemic pH. Am. J. Physiol. 260 (1991) H532-H541
12. Iansek R., Packham D., Aspey B., and Harrison M. An assessment of the possible protective effect of allopurinol in acute stroke. J. Neurol. Neurosurg. Psychiatry 49 (1986) 585-587
13. Itoh T., Kawakami M., and Yamauchi Y. Effect of allopurinol on ischemia and reperfusion-induced cerebral injury in spontaneously hypertensive rats. Stroke 17 (1986) 1284-1287
14. Kjellmer I., Andiné P., Hagber H., and Thiringer K. Extracellular increase of hypoxanthine and xanthine in the cortex and basal ganglia of fetal lambs during hypoxia-ischemia. Brain Res. 478 (1989) 241-247
15. Kleihues P., Kobayashi K., and Hossmann K.A. Purine nucleotide metabolism in the cat brain after one hour of complete ischemia. J. Neurochem. 23 (1974) 417-425
16. Ko K.M., and Godin D.V. Inhibition of transition metal ion-catalysed ascorbate oxidation and lipid peroxidation by allopurinol and oxypurinol. Biochem. Pharmacol. 40 (1990) 803-809
17. Liang C., Liu Y.P., and Chabner B.A. Modes of action of hypoxanthine, inosine and inosine 5′-monophosphate on cyclic nucleotide phosphodiesterase from bovine brain. Biochem. Pharmacol. 29 (1980) 277-282
18. Lin Y., and Phillis J.W. Oxypurinol reduces focal ischemic brain injury in the rat. Neurosci. Lett. 126 (1991) 187-190
19. Lin Y., and Phillis J.W. Deoxycoformin and oxypurinol: protection against focal ischemic brain injury in the rat. Brain Res. 571 (1992) 272-280
20. Lindsay S., Liu T., Xu J., Marshall P., Thompson J., Parks D., Freeman B., Hsu C., and Beckman J. Role of xanthine dehydrogenase and oxidase in focal cerebral ischemic injury to rat. Am. J. Physiol. 261 (1991) H2051-H2057
21. Markley J., Faillace L.A., and Mezey E. Xanthine oxidase activity in rat brain. Biochim. Biophys. Acta 309 (1973) 23-31
22. Marro P.J., Mishra O.M., and Delivoria-Papadopoulos M. Effect of allopurinol on brain adenosine levels during hypoxia in newborn piglets. Brain Res. 1073-1074 (2006) 444-450
23. Martz D., Rayos G., Schielke G., and Betz A. Allopurinol and dimethylthiourea reduce brain infarction following middle cerebral artery occlusion in rats. Stroke 20 (1989) 488-494
24. McPherson R.W., Zeger S., and Traystman R.J. Relationship of somatosensory evoked potentials and cerebral oxygen consumption during hypoxic hypoxia in dogs. Stroke 17 (1986) 30-36
25. Mink R.B. Comparison of early cerebral injury in rabbits after severe hypoxia, ischemia and hypoxia-ischemia. Crit. Care Med. 21 (1993) S204
26. Mink R.B., and Johnston J.A. A quantitative dot-immunoblot assay to measure protein in multiple brain samples. BioTechniques 20 (1996) 809-811
27. Mink R.B., and Johnston J.A. Changes in brain neurofilament and β-tubulin proteins after cerebral hypoxia-ischemia in rabbits. Pathobiology 68 (2000) 43-52
28. Mink R.M., Dutka A.J., Kumaroo K.K., and Hallenbeck J.M. No conversion of xanthine dehydrogenase to oxidase in canine cerebral ischemia. Am. J. Physiol. 259 (1990) H1655-H1659
29. Mink R.B., Dutka A.J., and Hallenbeck J.M. Allopurinol pretreatment improves evoked response recovery following global cerebral ischemia in dogs. Stroke 22 (1991) 660-665
30. Nakamura M., Araki M., Oguro K., and Masuzawa T. Differential distribution of 68 kD neurofilament proteins in the gerbil hippocampus and their early distributional changes following transient forebrain ischemia. Exp. Brain Res. 89 (1992) 31-39
31. Nishijima M.K., Koehler R.C., Hurn P.D., Eleff S.M., Norris S., Jacobus W.E., and Traystman R.J. Postischemic recovery rate of cerebral ATP, phosphocreatine, pH and evoked potentials. Am. J. Physiol. 257 (1989) H1860-H1870
32. Nishino T. The conversion of xanthine dehydrogenase to oxidase and the role of the enzyme in reperfusion injury. J. Biochem. 116 (1994) 1-6
33. Oka H., Kanemitsu H., Nihei H., Nakayama H., Tamura A., and Sano K. Change of xanthine dehydrogenase and xanthine oxidase activities in rat brain following complete ischaemia. Neurol. Res. 14 (1992) 321-324
34. Palmer C., Vannucci R.C., and Towfighi J. Reduction of perinatal hypoxic-ischemic brain damage with allopurinol. Pediatr. Res. 27 (1990) 332-336
35. Palmer C., Towfighi J., Roberts R.L., and Heitjan D.F. Allopurinol administered after inducing hypoxia-ischemia reduces brain injury in 7-day-old rats. Pediatr. Res. 33 (1993) 405-411
36. Peeters-Scholte C., Braun K., Koster J., Kops N., Blomgren K., Buonocore G., Van Buul-Offers S., Hagberg H., Nicolay K., Van Bel F., and Groenendaal F. Effects of allopurinol and deferoxamine on reperfusion injury of the brain in newborn piglets after neonatal hypoxia-ischemia. Pediatr. Res. 54 (2003) 516-522
37. Peterson D.A., Kelly B., and Gerrard J.M. Allopurinol can act as an electron transfer agent. Is this relevant during reperfusion injury?. Biochem. Biophys. Res. Commun. 137 (1986) 76-79
38. Phillis J.W., Sen S., and Cao X. Amflutizole, a xanthine oxidase inhibitor, inhibits free radical generation in the ischemia/reperfused rat cerebral cortex. Neurosci. Lett. 169 (1994) 188-190
39. Redzic Z.B., Gasic J.M., Segal M.B., Markovic I.D., Isakovic A.J., Rakic M.L., Thomas S.A., and Rakic L.M. The kinetics of hypoxanthine transport across the perfused choroid plexus of the sheep. Brain Res. 925 (2002) 169-175
40. Sakamoto A., Ohnishi S.T., Ohnishi T., and Ogawa R. Relationship between free radical production and lipid peroxidation during ischemia-reperfusion injury in the rat brain. Brain Res. 554 (1991) 186-192
41. Saugstad O.D., and Schrader H. The determination of inosine and hypoxanthine in rat brain during normothermic and hypothermic anoxia. Acta Neurol. Scand. 57 (1978) 281-288
42. Soloniuk D.S., Perkins E., and Wilson J.R. Use of allopurinol and deferoxamine in cellular protection during ischemia. Surg. Neurol. 38 (1992) 110-113
43. Spector R. Hypoxanthine transport and metabolism in the central nervous system. J. Neurochem. 50 (1988) 969-978
44. Szöcs K. Endothelial dysfunction and reactive oxygen species production in ischemia/reperfusion and nitrate tolerance. Gen. Physiol. Biophys. 23 (2004) 265-295
45. Uemura Y., Miller J., Matson W., and Beal M. Neurochemical analysis of focal ischemia in rats. Stroke 22 (1991) 1548-1553
46. 31P NMR study in unanesthetized immature rats. Neurosci. Lett. 144 (1992) 103-106
47. Zimmerman B.J., Parks D.A., Grishan M.B., and Granger D.N. Allopurinol does not enhance antioxidant properties of extracellular fluid. Am. J. Physiol. 255 (1988) H202-H206